Skip to main content
. 2016 Jun 17;7(33):53047–53063. doi: 10.18632/oncotarget.10132

Figure 3. Neurospheres formation impairment of PDGFRα-depleted GBM CSC vs control cells.

Figure 3

Microscopic analysis at 3 and 7 days in growth conditions reveals a diminished ability of p-CSC2 depleted of PDGFRα to make neurospheres in vitro compared to control cells (pLKO.1) over the entire course of the experiment.